The article you’re referring to reports on a Russian-developed cancer vaccine called
Enteromix, which has shown
100% efficacy and safety in clinical trials, according to claims from Russia’s Federal Medical and Biological Agency.
What Is Enteromix?
- It’s a personalized mRNA-based cancer vaccine, similar in technology to COVID-19 vaccines.
- It trains the immune system to recognize and eliminate cancer cells.
- The vaccine is tailored to each patient’s RNA profile.
- Initial applications target colorectal cancer, with versions in development for glioblastoma (brain cancer) and melanoma (skin cancer).
Trial Results & Next Steps
- Clinical trials reportedly showed tumor shrinkage, slowed growth, and no serious side effects.
- The vaccine uses four harmless viruses to attack tumors and boost immunity.
- It’s awaiting final regulatory approval before public release.
Should You Believe It?
While the results sound promising, it's important to note:
- These claims come from Russian state agencies and media, and independent peer-reviewed validation is not yet available.
- “100% efficacy” is an extraordinary claim that requires rigorous global scrutiny.
- Until published in reputable scientific journals and reviewed internationally, it’s best to stay cautiously optimistic.
Bing AI.